Context: Deficits in bone acquisition during growth may increase fracture risk. Assessment of bone health during childhood requires appropriate reference values relative to age, sex, and population ancestry to identify bone deficits.
B one tissue is responsive to metabolic, genetic, and behavioral factors. A variety of chronic health conditions are known to affect bone mineral accretion in children and may also result in poor growth and delayed maturation (1). Assessment of bone health in pediatric patients is important to identify children who may be at risk of poor mineral accretion or future risk of osteoporosis due to low bone mineral density (BMD).
Dual-energy x-ray absorptiometry (DXA) is the most widely used method for assessing BMD and is a good surrogate measure of bone health. It is ideal for pediatric use because of its wide availability, rapid scan times, and low radiation exposure. In healthy, normally growing children, DXA measures of bone mineral content (BMC) and areal BMD (aBMD) increase as a function of age and sexual maturation. Therefore, accurate assessment of bone health in children depends on robust reference data to determine whether an individual child's BMC or aBMD is comparable with same-age and -sex peers.
Total body and lumbar spine scans are recommended for clinical assessment of bone health in children (2) . Total body less head (TBLH) BMC or aBMD is preferred due to the changes in relative contribution of the head to total BMC and aBMD during growth and the importance of the postcranial skeleton in fracture risk assessment. However, there may be special circumstances for which the forearm or proximal femur may be the preferred scan site. DXA outcomes are influenced by bone size, so adjustment for body size is recommended for children, particularly those whose growth in height is at the extremes of the normal growth continuum (2, 3) .
Previously we reported reference curves for BMC and aBMD of the total body, lumbar spine, forearm, and proximal femur for children aged 7-17 yr from the Bone Mineral Density in Childhood Study (BMDCS), a large national cohort of children for whom standardized DXA measurements were obtained (4) . We also reported an adjustment procedure to account for tall or short stature relative to age (5) . These previous reports were based on initial study data. We now present the complete data collected during four additional annual evaluations with additional recruitment of younger and older participants to produce enhanced reference curves for children aged 5-20 yr, and corresponding height adjustment equations. (19 yr) participants to extend the reference percen-tiles from ages 5 to 20 yr. These subjects were evaluated annually for 2 yr (up to three visits).
Subjects and Methods

Study population
As described previously (4), the criteria for study entry were designed to acquire a multiethnic sample of healthy, normally developing children. These criteria included anticipated residence in the United States for 3 yr or longer; school placement within 1 yr of expected for age; term birth (Ն37 wk gestation or longer); birth weight greater than 2.3 kg; and no evidence of precocious or delayed puberty. For females, normal puberty was defined as onset of breast development at 8 -13 yr, onset of menses between 10 and 16 yr, and onset of pubic hair present at 7 y or older in African-American and Hispanic girls and 8 yr or older in non-Hispanic white or other ethnicities. For males, the criteria were testes size 4 ml or greater between 9 and 14 yr and pubic hair development at 9 yr or older. Children were excluded for two or more fractures if age 10 yr or younger, or three or more fractures if age older than 10 yr; current or previous medication use or medical condition known to affect bone health; extended bed rest; height, weight, or body mass index (BMI) outside the range of the third to the 97th percentile; indwelling hardware; or scoliosis.
Written informed consent was obtained from the study participants aged 18 yr or older. For participants younger than 18 yr of age, consent was obtained from the parent or guardian and assent was obtained from participants. The protocol was approved by the institutional review boards of each clinical center.
Bone densitometry
DXA scans were obtained using Hologic, Inc. (Bedford, MA) bone densitometers (QDR4500A, QDR4500W, Delphi A, and Apex models). One densitometer was used at each clinical center. The acquisition software versions varied slightly from version 11.1 to 12.7 (Apex 2.1).
Scans were obtained following manufacturer guidelines for patient positioning. Whole-body, posterioanterior lumbar spine (L1-L4, fast array), nondominant forearm, and left proximal femur (fast array) scans were acquired for each study participant. Cross-calibration of DXA devices and longitudinal calibration stability were monitored as previously described (4) . All scans were analyzed centrally by the DXA Core Laboratory (University of California, San Francisco, San Francisco, CA) using Hologic software version Discovery 12.3 for baseline scans. Hologic's Apex 2.1 software was used for follow-up scan analysis using the compare feature. By design, there are no differences in the Discovery and APEX software for scan analysis in subjects younger than 20 yr old. However, the use of the compare feature during analysis forced APEX software to use the same analysis as used for the baseline regardless of age. An in-study validation determined that there were no systematic differences between the software versions for scan analysis over the course of the study when these procedures were followed (data not shown).
Descriptive measures
The study methods were identical to those previously described (4) . Weight was measured on a digital scale, and height was measured using a stadiometer. Participants were dressed in examination gowns or light-weight clothing with shoes removed during the measurement. Height, weight, and BMI Z-scores were calculated using the 2000 growth charts from the Centers for Disease Control and Prevention (6) .
Information on population of origin (African-American, Asian, etc.) and ethnicity (Hispanic/Latino vs. non-Hispanic/Latino) was elicited by questionnaire using the National Institutes of Health and U.S. Bureau of the Census classifications.
Sexual maturity stage was assessed by an experienced physician or nurse skilled in pediatric endocrinology. For this report, puberty stage was based on breast development in girls or testicular volume by orchidometer in boys as determined using stan-dard clinical endocrine practice and according to the criteria of Tanner (7, 8) .
Statistical analysis
aBMD and areal BMC reference curves were created as previously described (4) . In brief, the power for the Box-Cox transformation, median, SD (LMS) approach (9) was used to generate BMC and aBMD curves relative to age using LMS Chartmaker version 1.16 (10) . Sex-specific curves were constructed for Black and non-Black groups for each DXA measurement site. The LMS analysis generates age-specific values for the median (M), SD (S), and power for the Box-Cox transformation (L), which are used to construct centile curves using equation 1 as follows:
where Z is the Z-score that corresponds to a given percentile. For an individual DXA measurement (X), the Z-score can be calcu- 
The fit of the centile curves was assessed by visual inspection as recommended in the software guidelines (10) on obtaining optimal L, M, and S parameter values and by comparison of the empirical centiles with the LMS-generated curves. The number of study participants over the age of 20 yr was sparse, so the age of all subjects with age 20 yr or older was recoded as 20 yr. Summary statistics were performed using Stata Version 10 software (StataCorp, College Station, TX) using the XTSUM procedure to account for the multiple observations per subject.
To confirm the need for separate curves for Black and non-Black groups, the non-Black reference curves were used to calculate Z-scores for subjects in the Black cohort. Mixed-effects regression analysis, accounting for multiple observations per subject, was used to examine these Z-scores. Age and sex trends were evaluated to determine whether separate curves for Black and non-Black groups were needed throughout childhood and adolescence.
We previously demonstrated an adjustment method for DXA outcome measures among children of short or tall stature using height Z-score (Ht-Z). Ht-Z, based on U.S. growth curves, can be calculated using the Epi Info Nutrition Calculator, a free software package available for download from the U.S. Centers for Disease Control and Prevention web site (http://www.cdc.gov/epiinfo/). The adjustment method requires three steps: 1) calculation of the BMC/aBMD for age Z-score (equation 2 above) and Ht-Z based on the U.S. growth curves; 2) calculation of a predicted BMC/ aBMD Z-score based on age and Ht-Z (equation 3 below); and 3) calculation of the adjusted BMC/aBMD Z-score using the predicted BMC/aBMD Z-score and the BMC/aBMD for age Zscore (equation 4). Adjustment equations based on the expanded sample size and age range were calculated using generalized estimating equations with the population average option to determine relationships between Ht-Z and BMC/aBMD Z-scores. Separate equations were constructed for each bone outcome ac- 
Results
Study sample
The sample consisted of 2,014 study participants (1022 girls) who completed 10,671 study visits. After study enrollment, 615 exclusion criteria were identified on 214 study participants as follows: medication use such as chronic steroid (number of observations was 260), anticonvulsants, oral isotrentinoin, psychiatric drugs; stimulants such as Ritalin, depoprovera/norplants (number of observations was 313); pregnancy (number of observations was 34); or serious illness (number of observations was eight) that might adversely affect bone mineral accrual. The final number of visits used for the creation of the reference curves was 10,066. Forty-one percent of subjects contributed seven observations to the final data set; 65% contributed at least four observations and only 7% had only one observation. The mean age was 13.5 Ϯ 4.2 yr. The race and ethnic distribution of the sample was 48% Caucasian, 24% African-American, 17% Hispanic, and 11% other. In keeping with the previously published reference curves from this cohort, all reference curves were based on the categorization of either Black or non-Black race based on the parent's report of the child's race. The distribution of observations across puberty stages were: 27% stage 1, 9% stage 2, 8% stage 3, 11% stage 4, and 45% in stage 5. Mean height, weight, and BMI Z-scores were significantly greater than zero (0.2 Ϯ 0.9, 0.4 Ϯ 0.8, 0.3 Ϯ 0.9, respectively). The percent of observations involving children with a BMI in the range of at risk of overweight (85th to 95th BMI percentile) was 16%, and for the overweight range (BMI Ͼ 95th percentile) was 6%, indicating that few were in the obese range according to the Centers for Disease Control and Prevention guidelines (11) . Height, weight, and BMI Z-scores were significantly greater (all P Ͻ 0.0001) for Black compared with non-Black children. Black girls were significantly (P Ͻ 0.001) younger than non-Black girls in prepuberty (7.7 vs. 8.1 yr, respectively) and at puberty stages 2-5 by 0.6 -0.8 yr, signaling earlier timing of sexual maturation. Black and non-Black boys significantly differed (P ϭ 0.001) in maturational timing only in puberty stage 4 (14.5 vs. 14.0 yr, respectively). Supplemental  Table 6 . The dotted line curves are the previously published BMDCS reference curves (4) for ages 7 to 17 yr based on a subset of observations used to generate the final curves. The error bar to the right of each curve shows the young adult (20 -29 yr) reference range (mean Ϯ 2 SD) from the NHANES (12).
DXA reference curves
Reference percentiles for TBLH BMC and lumbar spine aBMD are given in Tables 1-4 for Black and non-Black boys and girls ages 5-20 yr. Reference percentiles for BMC and aBMD of the total body, hip, femoral neck, and distal one third radius BMD, lumbar spine BMC, and TBLH aBMD are given in Supplemental Tables 1-10 , published on The Endocrine Society's Journal Online web site at http://jcem.endojournals.org. Each table also shows the L, M, and S values needed for calculating Z-scores using equation 2. The age-specific values shown are based on rounded ages; for example, the values for 10 yr olds should be applied to children who are 9.5-10.4 yr of age.
There was close agreement between the current curves and those previously published on a subset of observations and more limited age range (4) (see Supplemental Figures  1-5) . Figures 1 and 2 also show previously published total hip and femoral neck reference ranges from the National Health and Nutrition Examination Surveys (NHANES) for young adults (ages 20 -29 yr) based on data collected between 1988 and 1994 (12) . The median for the NHANES data are generally similar to the BMDCS curves ( Fig. 1) for total hip aBMD. However, the Ϫ2 SD levels are higher for the BMDCS curves compared with the NHANES data for both the total hip and the femoral neck sites. Total body BMC (TBBMC) and total body aBMD (TBaBMD) were compared with recently published NHANES results (13) (see Figs. 3  and 4) . The BMDCS and NHANES distributions for TBaBMD were comparable. For TBBMC, the median curves were similar, but the upper and lower reference percentiles for the NHANES data were broader than those provided in the BMDCS curves.
The previously noted pattern of greater BMC and aBMD for Blacks compared with non-Black subjects persisted. aBMD Z-scores and percentile ranks were computed for all participants using the reference values for non-Blacks. The median values for Black children were comparable to the 81st percentile for TBaBMD of the non-Black reference curves, the 70th percentile for spine, the 77th percentile for total hip, and the 75th percentile for radius aBMD of the non-Black reference curves. The difference between the Black and non-Black subsets was evident at all ages (data not shown), emphasizing the importance of separate reference curves for Black vs. non-Black children and adolescents.
Equations for calculating Ht-Zadjusted bone Z-scores
Ht-Z was significantly associated with all bone Z-scores. The highest R 2 were for TBBMC and TBLH BMC, ranging from 0.33 to 0.43. The equations for calculating Ht-Z-adjusted bone Z-scores are provided in each table.
Discussion
BMC and aBMD increase substantially during childhood and adolescence. Differences in body size and composition and maturational timing promote sex differences during this period. Consequently, BMC and aBMD must be evaluated as age-and sex-specific Z-scores to account for expected developmental changes in bone. Moreover, BMC and aBMD variability increases during adolescence. Therefore, a large healthy reference sample is essential to characterize the normal range of age-related changes in BMC and aBMD from childhood to adolescence. The results presented here describe BMC and aBMD from ages 5 to 20 yr based on about 10,000 observations of about 2,000 healthy participants from five centers in the United States. Standardized data collection methods were used, with centralized analysis of DXA scans to assure uniformity of results.
Many health conditions and medical therapies have been associated with poor bone acquisition. Primary bone disorders such as osteogenesis imperfecta as well as health conditions that involve chronic inflammation, malabsorption, immobility, hematological disorders, delayed sexual maturation, or gonadal insufficiency may adversely affect bone growth in childhood (14) . These may include disorders such as Crohn's disease, cystic fibrosis, cerebral palsy, thalassemia, acute lymphocytic leukemia, and anorexia nervosa. Medical therapies, such as glucocorticoids, also threaten bone acquisition. Pediatric reference data are vital for identifying poor bone acquisition in children who are affected by chronic illness and its treatment.
A subset of the observations presented here was used to create previous reference curves (4) . The revised and expanded curves described here closely correspond with the previous curves, which is an important consideration for clinicians who are already prospectively monitoring BMC or aBMD of children at risk for poor bone acquisition or who are receiving bone-active therapies. The median proximal femur aBMD values for the oldest age ranges in our study correspond approximately with published young adult reference ranges but differed in range of variation. This may be accounted for by use of different DXA technologies, sampling strategies, inclusion criteria, and statistical techniques for determining reference values as well as possible changes in aBMD during early adulthood. For all groups, differences in the Ϫ2 SD level between reference curves are relevant to longitudinal monitoring of at-risk individuals as they transition to adult care.
The recent NHANES TBBMC and TBaBMD data were acquired using Hologic DXA devices and analysis software similar to ours. NHANES and BMDCS reference curves for TBaBMD corresponded closely. For TBBMC, the NHANES and BMDCS median curves were similar, but the percentile ranges were greater in the NHANES curves compared with ours. The difference is peculiar because the NHANES BMC and aBMD data were obtained on the same subjects. It may be related to the construction of the reference curves because the shape of the curves will change as the number of degrees of freedom increases (15) . Differences between NHANES and the BMDCS in sample size, study design, and selection criteria may also account for curve differences, although this would not explain why our results are similar to NHANES for aBMD but not for BMC. Of note, we previously reported that total body measurements varied by as much as 4 -6% percent between centers (4). We did not apply corrections for center differences because we assumed this variability to be typical of that occurring at clinical centers at which our reference curves will be used for diagnostic purposes. The high degree of equipment-related variability in total body measurements suggests that the use of total body outcomes for diagnosing osteoporosis in childhood needs further scrutiny and validation.
Most DXA outcome distributions were skewed as denoted by L values that differed from one. Therefore, Z-score calculation based on a median and SD will give an inaccurate representation of a child's bone status relative to the reference population. We used the LMS technique to construct reference percentiles, which accounts for skewness and the nonlinear distribution. The Z-score calculation from the L, M, and S values (equation 2 above) is not simple but can be implemented in calculators and other programs to facilitate computations such as the one maintained on the BMDCS web site (www.bmdcspublic.com).
Children with health conditions that affect bone acquisition often have altered growth. Short or tall stature relative to age presents a challenge when interpreting DXA results because, on average, smaller bones have a lower BMC and areal aBMD than larger bones (5) . We provided correction factors for adjusting BMC and aBMD for height status. Although the height adjustment method is a three-step process, it provides the least biased adjustment for short (or tall stature), especially among children who are within the age range when normal timing of puberty occurs. Comparison of the age-based bone Z-score and the height-adjusted bone Z-score provides the clinician with a frame of reference for the degree to which the bone Z-score is influenced by short (or tall) stature. Fracture studies in children have clearly demonstrated the importance of adjusting for body size in the association between DXA bone outcomes and fracture risk (17) (18) (19) (20) (21) . Future studies are needed to evaluate the accuracy of the height Z-score adjustment method in identifying individual children at-risk for fracture.
The greater BMC and aBMD levels of Black vs. non-Black adults and children have been reported previously in studies using DXA (22) (23) (24) (25) (26) , peripheral quantitative computed tomography (27, 28) and spine computed tomography (29, 30). We quantified the magnitude of the dif-ference between Black and non-Black children using Z-scores based on non-Black reference curves. The Black cohort had mean Z-scores that were profoundly greater, ranging from 0.55 to 0.83. This result confirmed the need for separate curves so that bone health among children of African ancestry can be evaluated relative to their genetic potential for bone accrual. Greater BMC and aBMD in this group are consistent with lower fracture rates among people of African ancestry reported in studies in the United States (21, 31, 32) , the United Kingdom (33), and South Africa (16) . However, the relationship between fracture risk and BMC or aBMD Z-score among Black children remains to be determined.
The primary limitations of this study was the inability to acquire data on a randomly selected group of healthy children from all regions in the United States and the inability to apply these reference curves to the results from other DXA manufacturers. However, this robust sample, characterized using standardized methodology, offers the best pediatric reference data available.
Conclusion
We have extended previously reported pediatric DXA reference curves to encompass the age range from 5 to 20 yr for Black and non-Black children. These robust reference curves are based on about 10,000 observations in wellcharacterized healthy children using standardized techniques. As noted by the International Society of Clinical Densitometry Pediatric Recommendations, interpretation of DXA results in children should be based on sex, age, and group-specific reference ranges using similar DXA technology and analysis software and should be adjusted for body size. The results presented here significantly improve the information needed by clinicians for assessing and monitoring bone health in children, especially as they transition through adolescence and into young adulthood.
